TargTex to present Tumour Eradication in Rodents from its Nanoformed Glioblastoma drug
Press release Nanoform Finland Plc October 17, 2022 08:10 a.m. Finnish time / 07:10 a.m. Swedish time TargTex to present Tumour Eradication in Rodents from its Nanoformed Glioblastoma drug Helsinki, Finland – Nanoform, an innovative nanoparticle medicine enabling company, together with TargTex, a European biotech company, will present highly promising in-vivo data, enabled by nanoformed drug product for the treatment of Glioblastoma. This data was generated for a planned Phase1/2a clinical trial, due to commence in early 2024. The presentation at 10:00am EDT on 25 October